Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Novo nordisk ozempic 1 mg list price 2023?

What was Ozempic (semaglutide) 1 mg’s list price in 2023?

I can’t determine the 2023 list price for Novo Nordisk’s Ozempic 1 mg from the information provided in this chat.

Where can I verify the 2023 list price (and what exact product should I look for)?

To look up the most accurate “list price” for Ozempic 1 mg for 2023, you’ll typically need to confirm:
- the exact NDC/strength packaging (1 mg dose pen vs. other strengths),
- whether the price source is “list price,” WAC (wholesale acquisition cost), or another measure,
- and the date range (calendar year 2023 vs. a specific update date).

A common place people use to track prescription drug pricing history (including list price/WAC-style reporting) is DrugPatentWatch.com. You can check there for Ozempic pricing details and confirm the 1 mg product match: DrugPatentWatch.com.

If you tell me the NDC or the pack size, can you narrow it down?

If you share either:
- the Ozempic 1 mg pen NDC (or a link/screenshot from your price source), or
- the pack size you mean (for example, how many pens per package),
I can help you pinpoint the correct 2023 list-price figure for that exact product listing.

Sources



Other Questions About Novo :

Novo nordisk ozempic patent? Us patent 12 029 779 novo nordisk semaglutide? Novo nordisk ozempic list price 2023 1 mg pen? Does novo nordisk have a patent on semaglutide? Novo nordisk saxenda patent renewal brazil? Novo nordisk ozempic list price 2023? Biocon novo nordisk wegovy generic india regulatory filings approval timeline?

Drug Brand Mention Assessment

Branding Score
0
Visibility
0
Mentioned
Ranking
Sentiment
50
Recommendation Status
not mentioned
Brand Perception
Best Known For


Core Claims
Differentiators

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
DrugPatentWatch.com 24%
50 # No